Skip to Content
Merck
  • TIGAR deficiency enhances skeletal muscle thermogenesis by increasing neuromuscular junction cholinergic signaling.

TIGAR deficiency enhances skeletal muscle thermogenesis by increasing neuromuscular junction cholinergic signaling.

eLife (2022-03-08)
Yan Tang, Haihong Zong, Hyokjoon Kwon, Yunping Qiu, Jacob B Pessin, Licheng Wu, Katherine A Buddo, Ilya Boykov, Cameron A Schmidt, Chien-Te Lin, P Darrell Neufer, Gary J Schwartz, Irwin J Kurland, Jeffrey E Pessin
ABSTRACT

Cholinergic and sympathetic counter-regulatory networks control numerous physiological functions, including learning/memory/cognition, stress responsiveness, blood pressure, heart rate, and energy balance. As neurons primarily utilize glucose as their primary metabolic energy source, we generated mice with increased glycolysis in cholinergic neurons by specific deletion of the fructose-2,6-phosphatase protein TIGAR. Steady-state and stable isotope flux analyses demonstrated increased rates of glycolysis, acetyl-CoA production, acetylcholine levels, and density of neuromuscular synaptic junction clusters with enhanced acetylcholine release. The increase in cholinergic signaling reduced blood pressure and heart rate with a remarkable resistance to cold-induced hypothermia. These data directly demonstrate that increased cholinergic signaling through the modulation of glycolysis has several metabolic benefits particularly to increase energy expenditure and heat production upon cold exposure.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-TIGAR Antibody, from rabbit, purified by affinity chromatography
Sigma-Aldrich
ALLN, Cell-permeable inhibitor of calpain I (Ki = 190 nM), calpain II (Ki = 220 nM), cathepsin B (Ki = 150 nM), and cathepsin L (Ki = 500 pM).
Sigma-Aldrich
Cyclopiazonic acid from Penicillium cyclopium, ≥98% (HPLC), powder
Sigma-Aldrich
Rotenone, ≥95%
Sigma-Aldrich
Anti-Choline Acetyltransferase Antibody, Chemicon®, from goat
Sigma-Aldrich
MG-132, ≥95% by HPLC, Potent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM).